These results suggest that while LP.8.1 has lower pseudovirus infectivity than JN.1, its immune resistance is comparable to XEC and KP.3.1.1. NB.1.8.1 - This is the new mutation causing a spike in ...

such as pseudovirus assays and authentic assays; the company’s reliance on third parties with respect to virus assay creation and product candidate testing and with respect to its clinical ...